A stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of ...

Sanofi CEO Paul Hudson joins 'Squawk Box' to discuss the company's quarterly earnings results, drug pipeline outlook, the ...

As Sanofi prepares to halt U.S. marketing of its dengue vaccine in 2026, locally acquired infections in the country are ...

The funds will be used to advance Agomab’s candidates through clinical trials, including AGMB-129 for patients with ...

Sanofi SA (NASDAQ:SNY) and private equity Clayton Dubilier & Rice (CD&R) have finally entered into exclusive negotiations to ...

French pharamceutical giant Sanofi has confirmed plans to sell a controlling stake in its over-the-counter unit to a US ...

A health-care buyout has been sealed by an American firm against a rival Gallic offer. That’s despite the asset being a ...

PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its ...

The US buyout firm is pairing with the French pharma giant to buy out its consumer unit. Success here requires much more than ...

US private equity firm CD&R has agreed to French government demands seeking to protect jobs and investment in France.

Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, ...

French drugmaker Sanofi's announcement that it will sell a controlling stake in its consumer health division to a U.S.